SCHEMBL106364

SCHEMBL106364

CC(OC(=O)ON1CCN(CCC(=O)c2ccc3[nH]c(=O)oc3c2)CC1)c1ccc2cc[nH]c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 5/20 0.49
KCNH2 Q12809 2/20 0.48
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIN3A Q8TCU5 1/20 0.46
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
NUDT15 Q9NV35 1/20 0.38
CREBBP Q92793 1/20 0.37
ACHE P22303 1/20 0.36
HTR4 Q13639 1/20 0.36
MAPT P10636 3/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3050091 0.89 ENPP2 (0.58) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL105676 0.81 ENPP2 (0.62) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL15135277 0.78 ENPP2 (0.66) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL3051262 0.76 ENPP2 (0.61) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL104926 0.75 ENPP2 (0.67) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL2548653 0.75 ENPP2 (0.66) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL105919 0.75 ENPP2 (0.77) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL106566 0.74 ENPP2 (0.59) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL105610 0.72 ENPP2 (0.54) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL1907303 0.72 ENPP2 (0.67) ENPP2KCNH2GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP claimed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP claimed
EP-2426106-B1 Piperidine and Piperazine derivatives for the treatment of tumours MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed